Basis: (FMP quote price / unrounded diluted TTM EPS) / five-year diluted EPS CAGR in percent, from annual statements through the period end shown. Source: stored company filings and market data; unavailable inputs remain N/A.
The PEG ratio is N/A as of 2026-10-06T15:42:27.986Z.
Calculation as of: 2026-10-06T15:42:27.986Z.
Quote observation: 2026-10-06T15:40:24.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: ea97e6614670234c5dbfdf3bc7583d3b35e8d285e8978cbe73844bd7e5ba46ca
PEG RATIO
N/A
| NAME | MARKET CAP | PEG RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Krystal Biotech, Inc. (KRYS) | $9.75B | N/A | N/A | N/A | N/A |
| Henry Schein, Inc. (HSIC)vs › | $9.74B | 7.89 | 7.70 | 5.62 | 3.64 |
| Vaxcyte, Inc. (PCVX)vs › | $9.70B | N/A | N/A | N/A | N/A |
| Molina Healthcare, Inc. (MOH)vs › | $10.01B | N/A | 0.97 | 1.22 | 0.90 |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $10.03B | N/A | 0.04 | 0.21 | 0.23 |
| The Ensign Group, Inc. (ENSG)vs › | $10.14B | 1.98 | 1.96 | 1.71 | 1.34 |
| Insulet Corp. (PODD)vs › | $9.40B | 0.25 | 0.59 | 0.53 | 0.53 |
| Align Technology, Inc. (ALGN)vs › | $10.26B | N/A | 12.30 | 6.70 | 4.39 |
| Bruker Corporation (BRKR)vs › | $9.30B | N/A | 1.30 | 1.52 | 2.14 |
| Globus Medical, Inc. (GMED)vs › | $10.33B | 0.63 | 0.66 | 1.47 | 4.16 |
PEG Ratio
N/A
P/E Ratio
41.5
PEG Ratio = P/E Ratio / 5-Year Diluted EPS CAGR (%)
The PEG ratio divides the price-to-earnings ratio by the company's five-year compound annual growth rate of diluted EPS, expressed in percent. A P/E of 20 and a five-year diluted EPS CAGR of 10% give a PEG of 2.0. The growth is reported, historical earnings growth from annual statements, not an analyst forecast. A PEG near 1 is often read as fairly priced for its growth; lower can mean cheaper relative to growth. The ratio is N/A when the P/E is unavailable or not positive, or when the five-year diluted EPS CAGR is unavailable or not positive. Each day of the history uses the CAGR that was known on that day.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
